Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Gufic Bio
Gufic Bio
BSE: 509079NSE: GUFICBIOISIN: INE742B01025

6th-Aug-2019 21:05Source: BSE

Gufic Biosciences - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2019

GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, August 13, 2019, inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2019.

The Trading Window in respect of dealing in the Equity Shares of the Company, has remained closed for all the Directors and designated (specified) employees of the Company, with effect from July 01, 2019 until 48 hours after declaration of the Financial Results of the Company for the Quarter ended June 30, 2019. The Trading window in respect of dealing in the Shares of the Company shall reopen on August 16, 2019.
Kindly take the same on record.

Sections
Follow us on
Available On
PCI DSS Compliant